You're reading the free version. Trader adds the live tape and alerts.
Start tracking
FDMT Sale Disclosure
Bizily Scott · SEC Form 4 · Filed Jul 2, 2026
Sale
Calculated transaction value
$91.92K
Bizily Scott Chief Legal Officer
FDMT
Transaction date
Jun 30, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed 2 days later
FDMT daily price context
Close on/before transaction
$13.3
Jun 30, 2026
First close after public filing
$12.72
Jul 6, 2026
30-day return after filing
-20.68%
Through Aug 3, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 6,566 shares @ $14
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001920738-26-000004
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$132.62K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| 4d Molecular Therapeutics, Inc. FDMT | Exercise | Jun 30, 2026 | $37.33K |
| 4d Molecular Therapeutics, Inc. FDMT Current | Sale | Jun 30, 2026 | $91.92K |
| 4d Molecular Therapeutics, Inc. FDMT | Exercise | Jun 30, 2026 | $0 |
| 4d Molecular Therapeutics, Inc. FDMT | Exercise | Jun 30, 2026 | $0 |
| 4d Molecular Therapeutics, Inc. FDMT | Exercise | Jun 30, 2026 | $3.37K |